Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 7 Announcement Summary Entity name VECTUS BIOSYSTEMS LIMITED Announcement Type New announcement Date of this announcement Wednesday July 29, 2026 The +securities to be quoted...
Application for quotation of securities - VBS
Filed with ASX ·
6ix hasn’t read this filing yet.
Vectus Biosystems Limited on 6ix
Earlier from Vectus Biosystems
- Quarterly Activities & Appendix 4C Cash Flow Reports
- Placement of Shares
- Appointment of Dr Tara Speranza as CEO & CTO
- VB4-P5 Renal Compound Transaction Settled
- Half Year Report & Appendix 4D
Later from Vectus Biosystems
- Cleansing Notice
- Preliminary Final Report
- Full Year Statutory Accounts
- Change of Director's Interest Notice - MS
- Date of 2026 Annual General Meeting
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems